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Abstract:
Antibiotics, surgery and organ transplants have pushed average lifespans
towards the upper limits of the human body. Drastically reduced morbidity from
infection, toxins and traumatic injury have allowed ever greater portions of the
populace can reach eighty or ninety years old before dying of old age. Despite
the increased role of aging as a source of morbidity, many aspects of aging are
poorly characterized.
Sarcopenia, progressive muscle loss, and loss of adult myogenic
potential, the ability to produce new muscle tissue from adult stem cell sources,
are key causes of decreased mobility and strength in aged individuals. If more
youthful muscle quality could be restored in old patients they would experience
greatly improved quality of life and perhaps even longer lifespans. Satellite cell
populations are known to decline sharply by 6-7th decade of life but traditional
treatments for sarcopenia, namely exercise intervention, have been shown to
exacerbate the degeneration in aged such patients.
Previous studies have identified key regulators of the myogenic repair
pathway and implicated two regulators in aged sarcopenia: Notch and TGF-β. In
vitro expression studies have found that these genes act on the satellite cell, the
resident stem cell of adult muscle tissue, to regulate its ability to break
quiescence to begin regeneration and also show that genes show expression
defects during aging. Exogenous stimulation of the Notch receptor by calcium
chelators or protein ligands can be used to rescue/restore young regenerative
potential in old mouse cells and demonstrate that the defect is not cell-
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autonomous. This paper reports an in vivo pilot study to investigate whether a
calcium chelation method of Notch receptor stimulation and enhanced pathway
activation will rescue efficient regeneration in a mouse model of skeletal muscle
repair. Several candidate chelators are screened to test for toxicity as well as
pro-regenerative function.
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Introduction
Skeletal Muscle and Satellite Cell Overview:
Skeletal muscle fibers (myofibers) are very unusual cells: not only are they
a rare example of terminally-differentiated, multi-nucleated cells but muscle fibers
also contain repeated actin-myosin units called sarcomeres and a small nuclei to
cytoplasm ratio[1]. Myofibers contain large numbers of peripherally located
nuclei which reside along the length of the fiber just under the myofiber plasma
membrane (sarcolemma) and beyond the architecture of the sarcomeres.
Myofibers do not originate as single cells; myofibers result for the fusion of many
muscle progenitors whose fused plasma membranes give rise to the
sarcolemma[2]. Once incorporated into the muscle fiber these nuclei loose the
ability to divide. When muscle fibers are damaged myonuclei from other regions
of the fiber cannot proliferate to replace those losses nor can division occur at the
fiber level to replace fibers which are destroyed entirely[3].
Their inability to divide makes myofibers dependent on resident adult stem
cell populations for tissue homeostasis and repair. The resident stem cell of
skeletal muscle tissue is known as the satellite cell and although other cell types
have been shown to be able to contribute to muscle repair, the large majority of
regeneration results from satellite cells and their progeny [1]. Satellite cells make
up only ~4% of the nuclei within adult muscle yet maintain the integrity of the
entire tissue [4]. However in aged patients satellite cell numbers drop to .6%3.4% of nuclei present within the muscle [3]. These cells can be characterized
by a larger nuclear to cytoplasmic ratio, residence between the sarcolemma and
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basal lamina and a number of marker proteins such as M-cadherin, Pax7 or
NCAM [1]. These small, largely quiescent cells play a pivotal role in muscle
tissue maintenance and regeneration. When actively dividing, satellite cells are
capable of producing large numbers of muscle progenitors as well as renewing
the satellite cell pool in neighboring muscle tissues. Satellite cell-derived muscle
progenitors are the only means by which myonuclei can be replaced and can
even give rise to entirely new fibers [3].
Like many stem cells, satellite cell division leads to two distinct
populations: additional satellite stem cells, also known as renewal cells, and
transit-amplifying cells [6]. Transit-amplifying cells are the transitory progenitor
cells which proliferate and mature into the new differentiated muscle tissue
needed immediately after injury. Renewal cells, on the other hand, are vital for
long term muscle maintenance because these cells can replenish satellite cell
numbers and ensure that regenerative potential is not consumed by successive
rounds of regeneration [6]. The expenditure model posited that myogenesis was
dependent on a progenitor cell with a finite number within an adult, such as
oocytes, and that as progenitors were expended after each injury the myogenic
potential of the tissue would decrease until even tissue homeostasis could no
longer be maintained. The identification of renewal cells falsified this model and
led to investigations of signaling changing in aged stem cells.
Satellite cell-mediated myogenesis follows a well characterized path of
differentiation which starts with activation of the satellite cells near the site of
injury [7]. Activation then leads to the formation of a transit-amplifying cell: the
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myoblast. Myoblasts are partially differentiated cells that undergo successive
rounds of division to proliferate and form myocytes. In parallel with this
proliferation the area of cell death becomes inflamed and dead tissue is removed
by macrophages and other immune cells that infiltrate from the circulatory
system. After proliferation is complete myocytes can either fuse with damaged
fibers to replace lost nuclei or fuse with each other to form nascent myotubes.
Myotubes show many of the characteristics of myofibers but can be distinguished
by prominent, centrally located nuclei that migrate the outer edges of the plasma
cell membrane upon maturation [5].
Transit-amplifying cells, in contrast, move out of the satellite cell niche,
partially differentiate and under go vigorous proliferation to produce large
numbers of muscle precursors: myoblasts [7]. These myoblasts further mature
either by fusion with damaged muscle fibers or by synchronous membrane fusion
with other myoblasts. Fusion with existing fibers promotes repair while mass
fusion with other myoblasts allows de novo formation of myotubes. Myotubes
undergo a final round of differentiation as they assemble actin-myosin contractile
machinery and move their centrally located nuclei to the periphery[6]. Once
these changes are complete myotubes become terminally differentiated
myofibers and begin to take part in normal muscle contractions. Upon complete
differentiation these newly formed myofibers establish new satellite cell niches
which can be colonized by satellite cells, such as those from the renewal
population [2].
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Satellite Cell Niche and Breaking Quiescence:
Later studies instead upheld a niche model of age-based degeneration
which posited that the muscle environment undergoes changes during the aging
process that inhibit proper regeneration despite ample supply of relevant repair
cells. One critical change uncovered during the aging of the muscle niche is the
imbalance of Notch and TGF-β [7]. As muscle ages TGF-β levels rise until
muscle regeneration becomes compromised and degeneration begins [8].
Studies also found that exogenous stimulation of Notch receptors could restore
regenerative function despite high levels of TGF-β signal [6,10]. This
phenomenon was eventually linked to the ability for satellite cells to break
quiescence despite defective signaling in the niche [9]. High TGF-β induces
rapid up-regulation of Cyclin-Dependent Kinase inhibitor (CDKi) genes,
preventing the satellite cell from properly activating and engaging in productive
repair [10]. Activated Notch was discovered to physically outcompete
downstream TGF-β signaling effectors for their affinities to CDKi promoter
regions[10].
Satellite cells are normally quiescent, only actively proliferating in
response to external signals. As resident stem cells, satellite cells particularly
benefit from the lower mutation load and resistance to damage that result from
long periods of quiescence. It is therefore unsurprising that breaking quiescence
requires successful transduction of pro-regenerative signals or that there are
endogenous signals (such a TGF-β) which maintain the quiescent state. It is

11
possible that together Notch and TGF-β allow satellite cell sensitivity to be
adjusted so that mass activation and the production of transit-amplifying cells
only occurs during injury when the production of such cells is more valuable than
maintaining a low mutational load within the satellite cell population.
Studies of satellite cell activation revealed that if old satellite cells were
able to break quiescence despite high levels of TGF-β, their transit-amplifying
progeny were able to complete myogenesis efficiently[8]. These results
suggested that this singular defect in satellite cell regulation was largely, if not
completely, responsible for the drop in myogenic potential observed in aged
patients.
The Notch Receptor:
The Notch receptor is a single pass trans-membrane receptor (see Figure
2) which undergoes proteolytic cleavage in the Golgi network and is trafficked to
the plasma membrane as a hetero-dimeric complex [9]. It has been
experimentally demonstrated that calcium depletion by treatment with EDTA is
sufficient to induce dissociation of the Notch extra cellular domain (NEC) [13].
Without NEC the remaining Notch protein undergoes a conformational change
which leads to release of the intracellular domain (also called active notch or
Notch*) from its membrane anchor [13]. Once released from the membrane,
Notch* is free to diffuse throughout the cytoplasm where it is known to traffic into
the nucleus [9].
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Figure 1- Histological Artifacts
The newly formed fibers can be easily distinguished from both resting muscle
and non-muscle cellar materials. (Left) This field shows normal resting muscle.
Resting myofibers can be recognized by their large eosin-retaining cytoplasms
and their peripherally located nuclei. The white river-like gaps between some
of the myofibers of this field are stretching artifacts which result from the
sectioning process and do not reflect actual gaps that existed in the muscle
before removal from the animal. (Right) This field also shows resting muscle.
The jagged white shapes within the cytoplasm of these cells are also an artifact,
resulting from the cyro-freezing process. If jagged ice crystals form during
freezing they can damage the cell membrane and prevent proper staining,
resulting in unstained sections of cytoplasm or nucleus.

Once within the nucleus the Notch* fragment can act as a transcription
factor and activate the expression of genes such as CBF-1[16]. It has been
suggested that the calcium dependent stability of the Notch complex reflects
direct coordination of calcium ions by the amino acids of one or more subunits
but further experimentation is needed to confirm this possibility[12]. The low
stability of Notch* remains an obstacle to more thorough characterization of the
Notch signaling pathway.
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Figure 2 – Structure of Notch Receptor
(Reproduced from Chillakuri et. al. 2012, citation [12] in references)
The Notch receptor has three calcium binding sites in its extracellular
domain. The red spheres in the ribbon diagram represent the location of
calcium ions when bound by Notch. These interactions are key to
suppressing proteolytic activation of the active Notch fragment. The
proteolytic cleavage to produce Notch* occurs between the HD and RAM
domains on the cytoplasmic side of the cell membrane.

Investigations into structure and activation of Notch revealed that Notch is
endogenously activated by membrane-bound protein ligands such as Jagged or
Delta [12,14]. These proteins can act on Notch receptors during cell-cell contact
and induce changes in Notch to produce the active Notch (Notch*) fragment after
proteolytic cleavage. Binding of the correct ligand to Notch’s extracellular
domain results in a trans-membrane signal that targets the Notch intracellular
domain for cleavage[12]. The resulting cleavage frees the Notch* fragment of
the intracellular domain for its membrane tether. Once able to diffuse freely
throughout the cell Notch* is trafficked to the nucleus where it acts as a
transcription factor and establishes expression levels favorable for satellite cell
activation [14]. Notch characterization studies also revealed that soluble,
recombinant proteins of these ligands had an antagonistic effect on Notch
signaling and blocked positive signaling [15]. Recombinant ligands would work
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like their endogenous counterparts only if anchored to ECM, cell membranes or
other semi-rigid structures [15].
While immobilized proteins are easy to introduce in a culture dish it
presents a substantial barrier to clinical applications of Notch agonists. Muscle
tissue is deep and incurs damage with each needle insertion; a soluble
therapeutic would be able to be delivered by fewer injections, reducing needle
damage, and distribute more evenly throughout the injury. Structural
characterizations of the Notch protein revealed calcium ion interactions within the
protein structure and it was found that calcium depletion could lead to Notch
activation, although by a different mechanism than Jagged or Delta signaling
[13]. Without ample calcium supply the Notch receptor’s extracellular domain
undergoes structural changes which induce activation of the intracellular domain.
In this manner calcium depletion mimics ligand binding at the regulatory domain
and transmits it to the active domain within the protein.
Calcium Chelators:
Soluble calcium chelators, especially EDTA, are well characterized small
molecules which can dramatically decrease the concentration of free calcium
ions in solution [13]. The electron rich hetero-atoms of the EDTA and similar
compounds have a high affinity for the empty orbitals of the calcium ion and the
reversible reaction equilibrium strongly favors the chelate product (Figure 4).
Formation of this chelate depletes free calcium which is a reactant for the Notchcalcium equilibrium. Depletion of a reactant favors the reverse reaction and thus
Notch-calcium complexes destabilize as free calcium levels drop. Ultimately the
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affinity of EDTA for calcium is high enough to destabilize a large number of
Notch-calcium complexes which in turn produces Notch* and positive Notch
signaling [13].

A

B

Figure 3 – Histology of Injury and Regeneration
(A)A field of newly regenerated fibers. Regenerated fibers could be newly
formed fibers or existing fibers that recently underwent repair. In both cases
these fibers can be distinguished from their resting counterparts by their
central nuclei and increased interstitial space. As these fibers mature the
spaces between them will shrink while their nuclei move to just below the
surface of the plasma membrane. (B) An area of injury without subsequent
regeneration. There are a large number of cell nuclei in the center of the field,
but these cells do not possess large cytoplasm nor strong eosin-staining. These
cells might be immune cells, fibroblasts, adipocytes or incompletely
differentiated muscle precursors.
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Figure 4 – Calcium Chelators and Coordination Structure
A)) The structure of EDTA. B) The structure of EGTA. C)) The structure of
BAPTA, note this chelator contains two aromatic rings. D) The
coordination confirmation of soluble EDTA while chelating a divalent
cation (reproduced from )).. Although the structures are shown in
unionized form, in aqueous solution the acidic hydrogen atoms within
each molecule’s carboxyl moieties would ionize to yield carboxyl-anions.
carboxyl
It is the anionic species which is responsible for the hexa-dentate
dentate
coordination of metal cations.
Specific Aims:
The ultimate purpose of this pilot study was translate previous work on
calcium-depletion
depletion Notch activation into an in vivo model. The experiments were
designed to reveal any off-target
target effects or efficacy concerns which might render
chelation a poor clinical tool. It was hypothesized that calcium chelation would
lead to local Notch activation and greatly increase successful regeneration with
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minor side effects, such as transient inability to form blood clots, but no side
effects which might disqualify for further testing. To test this old, and therefore
regeneration impaired, mice were injured and later injected with chelators.
Additional mice were injected only with a chelating agent and used to screen for
possible off-target effects that might be obscured by the cardio-toxin injury.
Finally control mice were injected with solvent solutions ensure any effects
observed could be confidently ascribed to the chelators.
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Materials and Methods

Figure 5 – Experiment Flowchart
A) Mice are subjected to acute injury via CTX injection to the TA and
Gastrocnemius muscles of both legs. B) Successive activation of satellite
cells is stimulated by calcium chelation. C) Mice are cervically
dislocated so their leg muscles can be harvested and embedded for
histology. D) Embedded muscle samples are sliced into histological
sections, fixed and stained with Eosin and Hematoxylin to allow for
identication of regenerated fibers. E) Histological sections from each
muscle are imaged using a bright field microscope and regeneration in
quantified in ImageJ to produce final histogram (next figure).

In this pilot study, cardiotoxin (CTX-1) obtained from Sigma-Aldrich was
used to produce local cytotoxicity and acute muscle injury in old mice via
intramuscular injections of CTX-1 into the tibialis anterior and gastrocnemius.
Mice were handled and sacrificed in accordance with the UConn Health Center
animal care policies. Injections of CTX-1 produce well characterized,
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reproducible injuries [16]. The mice received 10 microliter injections of 0.1
microgram per microliter cardiotoxin in phosopho-buffered saline for a total
injection of 1 microgram of toxin. This injection creates a pocket of cell death in
the center of the muscle belly emanating from the needle track. During recovery
this pocket is cleared of dead muscle fibers and colonized by new tissue; in
regeneration-competent mice the injection pocket becomes filled with newly
formed and repaired muscle fibers, while in regeneration-impaired mice the area
of fiber death becomes infiltrated by neighboring tissues, immune cells or
acellular fibrosis.
Three days following initial injury mice were injected at same site within
the muscle belly with a calcium chelating agent: EDTA, EGTA, BAPTA or a
control saline solution. The chelators were injected at 2mM and 5mM
concentration into left or right legs respectively. These concentrations were
chosen based on previously conducted titration studies (data not shown) which
indicated that these concentrations were capable of inducing Notch activation
following injury in 10 month old mice. Chelating agents were introduced on the
third day following injury because that time point coincides with the time of
maximal satellite cell activation in regeneration-competent young mice.
Three days post-injury was also chosen for injection of the chelator to
avoid any confounding interactions between the calcium chelators and the
calcium-dependent toxic mechanism of the cardiotoxin had they been coinjected. After injection with a chelator, the mice were allowed to recover until
seven days post injury when they were sacrificed and their muscles harvested for
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analysis. At seven days post injury newly regenerated fibers can still be
distinguished from resting fibers by their centrally located nuclei.
Once harvested, the injected muscles were imbedded into cutting media
and then processed into tissue micro-sections sections of the muscle crosssections. These tissue sections where stained with Eosin and Hematoxylin so
that regeneration could be examined and quantified histologically. Newly formed
myotubes retain centrally located nuclei within their syncytium while matured
fibers possess nuclei pushed to the boarder of the plasma membrane. Fibers
were identified or excluded as regenerated by observing the position of their
nuclei in cross-section using bright-field microscopy. These images were
processed using two ImageJ features: manual cell counting and pixel area
measurement. Regenerated fiber counts, normalized for area of regeneration,
were used as the metric of regenerative efficiency. Regenerative efficiency for
each condition was determined using three replicate sections from the same
muscle while error bars were created using standard deviation.
Statistical Analysis:
For the quantitative data presented all conditions were based on three
replicate sections from each muscle but each condition was tested in a single
mouse. Statistical significance was determined by the results of a two-tailed Ttest. Differences with P < .02 were considered statistically significant.
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Results
Rescue of Regeneration:

Figure 6- Post-Injury Calcium Chelation Increases Regeneration
To determine the effects of calcium chelation on regeneration, mice were
injected with cardiotoxin (CTX-1) to induce acute injury in the gastrocnemius
muscle. At three days post injury the mice were injected with a calcium chelating
agent, or phosphor-buffered saline (PBS) control solution, to induce Notch
activation and rescue regenerative function. Regenerative function was
determined by regenerated fiber count per unit area within histology fields.
Error bars represent 1 standard deviation from the mean. All three calcium
chelators (EDTA, EGTA and BAPTA) show statistically significant increased
regeneration (indicated by *) at both 2 mM and 5 mM as compared to the two
control solutions with P < .02. These results are consistent with calciumdepletion mediated Notch activation and Notch-mediated rescue of regenerative
function.

All of the tested concentrations of calcium chelator resulted in statistically
significant increases in regeneration (Figure 5). These results are exactly what
was expected based upon previous in vitro experiments and present histology
akin to younger mice. There is an unusual decrease in regeneration in the higher
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concentration of EGTA as compared to the lower concentration of EGTA. This
difference was not statistically significant, but additional toxicity screens should to
be conducted to quantify any myotoxic characteristics in the chelators.
Though there were no statistically significant differences in regenerative
efficiency between the three chelators or either concentration, there was a
noticeable increase in spacing between the fibers at 5mM of any chelator as
compared to 2mM of the chelator (Figure 6). This phenomenon was not
observed in titration studies but inter-fiber spacing could not be reliably quantified
in those studies either. Representative samples of each condition have been
included below.
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Figure 7 – Representative Histology Fields
(A) Saline Control (B) CTX Control (C) EDTA 2mM(D) EDTA 5mM
(E) BAPTA 2mM (F) BAPTA 5mM (G)EGTA 2mM (H) EGTA 5mM
Note: All fields in this figure are at the same scale.
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Chelation-Induced Injury:

A

B

Figure 8 – Cytotoxicity of Chelators
A) Muscle injected with control solutions at both day 0 and day 3 show no
evidence of injury. B) Muscle injected with a control solution at day 0 and
a calcium chelator at day 3 show evidence of fiber death, increased
clustering of nuclei but very little regeneration. Field B superficially
resembles the failed regeneration histology found in old injured mice. This
cytotoxicity was not found in the case of BAPTA

Those mice injected with only the calcium chelator at day 3 show the
histological hallmarks of injury with no clear signs of regeneration and bled for
longer from these wounds. The presence of the chelator is the only difference in
the injection received by these mice and the control mice it can be inferred that
the injected concentration of chelator is toxic to resting fibers (Figure 3 and 8). It
should be noted that samples were harvested at day 7 which is only four days
after injury is believed to have taken place. Therefore the regeneration, or lack
there of, observed in these fields cannot be directly compared to the muscles
injured with cardio-toxin at day 0. It is unclear if these muscles might have
shown any regeneration had they been harvested at three day.
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Discussion
Potential Application for Acute Muscle Injury:
The results of this pilot study suggest that calcium chelators represent a
viable treatment to promote productive muscle regeneration in old injured
patients and that more robust testing should be conducted. The statistically
significant increase of regeneration in calcium chelator-treated muscle injuried is
consistent with the model that calcium chelation leads to widespread activation of
Notch signaling in previously quiescent satellite cells. Once assisted to break
quiescence these old satellite cells are able to follow the myogenic pathway from
amplification to complete myotube development without further intervention.
Chelation therapy could be extremely useful in areas with poor access
healthcare. Because therapy is administered three days post-injury patients who
must travel or wait to seek medical assistance, especially in cases where injury
has rendered the patient unable to walk, could still receive the chelator at the
optimum time. Aqueous chelator solutions are also relatively stable and could be
stored for short periods without refrigeration, making them easier to deploy in
areas with poor medical infrastructure than recombinant proteins or other
pharmaceuticals.
Toxicity to Resting Fibers without Regenerative Induction:
Despite the pro-regenerative effects of these chelators, it also
appears that calcium chelation is toxic to resting muscle fibers and does not
promote subsequent regeneration.
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Several mechanisms might explain these results; the chelating agents
could be toxic at the injected concentration but as the agent diffuses towards the
edge of an injured area the concentration drops below the cell death threshold
but remains above the threshold to activate Notch. Since the area of injection is
already largely clear of cells at day 3 post injury, there is no significant loss near
the injection site but the neighboring satellite cells are still activated to begin
regeneration. Alternatively calcium chelators are generally toxic to resting
myofibers but only induce activation in satellite cells that have been sensitized by
other injury signals such as inflammation or have moved into the wound where
they are more exposed than when between the sarcolemma and basal lamina.
In this case injection of the chelator caused injury but not regeneration because
the Notch stimulation occurred before satellite cells were sensitized by other
niche factors. Most likely, the observed histology reflects the fact that these
injuries have not had enough time to clearly show regeneration and that chelator
injection at day 0 instead of day 3 might have yielded opposite results.
Additional experiments are needed establish whether chelators alone can
induce both injury and regeneration, specifically assays of regeneration seven
days post-injury in mice injected with chelators at day 0, day 3, and both days
along all necessary controls. Such an experiment would confirm or deny whether
the lack of regeneration observed was an artifact resulting from harvesting the
muscle too early after injury or reveals a dangerous side-effect of therapy.
If chelators are toxic to healthy tissue but only induce regeneration in
already injured tissue, chelation therapy is only beneficial when a patient has
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undergone an acute injury, such a surgery, where both the time and area of
injury are well defined. In such cases chelation could be injected in a confined
area to bolster regeneration to the injured area and minimize damage to
surrounding tissues.
If chelation is toxic to resting muscle but also induces regeneration without
prior injury then chelation therapy could be used in cases where injury is present
but the area of injury is poorly defined. In this case any off target use of
chelators would result in unnecessary but ultimately successful regeneration with
minimal risk to long term tissue function.
Regardless of the need for prior injury, chelation’s toxicity to resting
muscle suggest chelation therapy is a poor treatment for chronic degeneration
such as sarcopenia which does not produce a contiguous area of injury which
could be targeted for chelation [17]. Sarcopenia treatment might be better
addressed by a non-toxic means of inducing global, prolonged, low-level
activation of Notch to allow for slight global regeneration to counterbalance the
sarcopenia-mediated global degeneration [18]. Calcium chelators do not appear
to fit these criteria.
Future Directions:
The results of this paper present several opportunities for additional
research. First and foremost these experiments are ultimately a pilot study and
this work should be reproduced in a larger sample size. A larger pool of mice,
perhaps multiple mouse lines, could reveal any differences between lines and
confirm that these results do not reflect a small sample size. Some of the
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chelating agents tested, specifically EDTA, have already received FDA approval
for treatment for heavy metal poisoning and therefore would be ideal candidates
for eventual human clinical testing.
However a major caveat of these results is that Notch activation has only
been inferred by increased regeneration in this study. A followup study using
muscle harvested at four days post injury (one day post chelation) or even
sooner, and subsequent immuno-histochemical detection of the Notch* fragment
are needed to confirm that Notch activation actually occurred while experiments
comparing chelation with or without co-injection of a Notch antagonist, such as
soluble Delta, are needed to test if Notch activation shares a casual link with
regeneration rescue [15]. Calcium is known to regulate a large host of biological
processes; it is possible that the rescue observed is due to calcium-mediated
changes in other signaling pathways [19]. The prominence of Notch in many
stem cell regulatory networks [20] requires that off target effects be extensively
characterized.
Given these results, optimization studies should also be conducted to test
if the chelator toxicity can be eliminated without compromising Notch activation.
Such alterations would allow calcium chelation to be serious considered for long
term use as treatment for chronic conditions like sarcopenia. If such optimization
fails future researchers could consider a more selective molecule that specifically
strips the Notch receptor of calcium ions, rather than pull all such ions out of
solution. Even so, the Notch receptor plays a role in many other pathways
relevant to the injury-adjacent environment, especially angiogenesis [20].
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Neighboring neurons, vessel endothelial cells and osteocyte progenitors which
express Notch could be effected in significant ways even by a Notch-specific
stimulant [20]. As with all injury inflammation can occur, but injury macrophages
are known to play a role in proper regeneration of skeletal muscle and therefore
any effects on these cells must also be studied in the context of chelation therapy
[21].
During this study it was also observed that mice bled more from injections
of calcium chelators. It is suspected that transient inability to clot results from the
inability to activate a calcium-dependent clotting factor. Future studies should be
conducted to quantify this observation with proper controls and ensure that poor
clotting post-treatment does not pose a significant threat to patients. The
depletion of free calcium almost certainly effects the ability of local neurons to
generate action potentials. Neural excitotoxicity, for example, would both
negatively impact the niche and possibly effect regeneration: de novo fibers
might have a critical window for forming neuromuscular junctions post-injury.
Although chelation treatment is meant for older patients, future longitudinal
studies of repeated injury, activation and regeneration should be conducted. It is
unclear how the self-renewal pathway of satellite cells may be effected by strong
Notch activation. If chelation suppresses the formation of the renewal cell
population then long-term use of this treatment could deplete the muscle of
satellite cells entirely.
In conclusion, the results of this study demonstrate that calcium chelators
can rescue skeletal muscle regeneration in mice with age-based regenerative
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defects. These results show promise as means to translate Notch-mediated
regenerative rescue into the geriatric clinic. If these results hold up under more
robust testing conditions and replication, then testing in an alternative animal
model and eventual human testing can begin.
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